Home Stock Market How Is Dollar Tree’s Stock Performance Compared to Other Consumer Defensive Stocks?
Stock Market

How Is Dollar Tree’s Stock Performance Compared to Other Consumer Defensive Stocks?

Share


Growth & Income by Koto Amatsukami via Shutterstock

Growth & Income by Koto Amatsukami via Shutterstock

With a market cap of $22.1 billion, Dollar Tree, Inc. (DLTR) operates discount variety stores across the United States and Canada under the Dollar Tree and Dollar Tree Canada brands. The company offers a wide range of consumables, variety merchandise, and seasonal goods, catering to everyday needs as well as holidays and special occasions. 

Companies worth more than $10 billion are generally labeled as “large-cap” stocks and Dollar Tree fits this criterion perfectly. Supported by a nationwide logistics network and its e-commerce platform, DollarTree.com, the retailer serves individuals, small businesses, and organizations with affordable products and bulk purchasing options.

Despite this, shares of the Chesapeake, Virginia-based company have declined 19.8% from its 52-week high of $142.40. DLTR stock has risen 2.4% over the past three months, slightly outperforming the State Street Consumer Staples Select Sector SPDR ETF’s (XLP) 1.5% gain over the same time frame. 

www.barchart.com

In the longer term, shares of the company have increased 19% over the past 52 weeks, outpacing XLP’s 4.3% return over the same time frame. However, DLTR stock is down 7% on a YTD basis, lagging behind XLP’s 10% increase.

Despite a few fluctuations, the stock has been trading below its 50-day moving average since last year. Also, it has fallen below its 200-day moving average since September 2025.

www.barchart.com

Shares of DLTR climbed 17.9% on May 28 after Dollar Tree reported strong Q1 2026 results, with net sales rising 7.2% to $5 billion, comparable-store sales increasing 3.5%, and adjusted EPS surging 38.1% to $1.74. Investors were encouraged by significant profitability improvements, as operating income increased 23.2% to $473.3 million and operating margin expanded 120 basis points, driven by higher mark-ons, lower freight costs, and reduced shrinkage. 

Sentiment was further boosted by the company raising its full-year fiscal 2026 adjusted EPS guidance to $6.70 – $7.10, repurchasing $595 million of shares during the quarter, and maintaining expectations for 3% – 4% comparable-store sales growth and approximately 400 new store openings.

However, rival Target Corporation (TGT) has outpaced DLTR stock. TGT stock has increased 38.2% on a YTD basis and 36.1% over the past 52 weeks.

Due to the stock’s weak performance relative to its peers, analysts remain cautious on DLTR. The stock has a consensus rating of “Hold” from the 26 analysts in coverage, and the mean price target of $124.45 is a premium of 8.9% to current levels.

On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.



Source link

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss

These Are the Consequences of Chicago Bears Megaproject

Developers in Chicago should be licking their chops.Tweaks to the so-called megaprojects bill passed by the Illinois House this week to keep the...

British Pound fills weekly gap vs USD; UK politics, Fed cap upside

The GBP/USD pair climbs back to the 1.3235 region during the Asian session and fails the weekly bearish gap opening amid a modest...

Related Articles

Defensive stocks in the S&P 500 hit a near-historical low, last seen in 2000.

Author: Jim PaulsenCompiled by Deep潮 TechFlowDeepInsight Summary: The weight of defensive stocks...

Dow Hits Record as Chip Selloff Deepens for a Second Day; Nasdaq Falls 0.8%

Semiconductor shares continued to fall on Wall Street as sector rotation left...

Q3 Stock Market Outlook: What’s In and What’s Out

Key TakeawaysThe climb in market-beating US small caps will continue as valuations...

Bristol Myers Squibb (BMY) Joins Defensive Value Indexes, Is It Still 8% Undervalued?

Bristol-Myers Squibb (BMY) is being reclassified across key Russell indexes, exiting several...